c-myc in the hematopoietic lineage is crucial for its angiogenic function in the mouse embryo

Development

Volumn 135, Issue 14, 2008, Pages 2467-2477

  He, Chen ^a,d   Hu, Huiqing ^a   Braren, Rickmer ^a,e   Fong, Shun Yin ^a,f   Trumpp, Andreas ^b,c   Carlson, Timothy R ^a,g   Wang, Rong A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

^c EPFL   (Switzerland)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f Estrada Control Nicolau de Mesquita   (Macao)

^g ABBOTT VASCULAR   (United States)

Author keywords

Angiogenesis; c myc; Hematopoiesis; Mouse; Myc; Vascular development; Vasculogenesis

Indexed keywords

MYC PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; FETUS; GENE DELETION; HEMATOPOIESIS; HEMATOPOIETIC CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; SURVIVAL;

ANIMALS; CELL LINEAGE; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; EMBRYO, MAMMALIAN; ENDOTHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; GENE DELETION; HEMATOPOIETIC SYSTEM; IN SITU NICK-END LABELING; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS C-MYC; TIME FACTORS;

MAMMALIA;

EID: 50249134311     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: 10.1242/dev.020131     Document Type: Article

References (65)

1. Adams, R. H. and Alitalo, K. (2007). Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell Biol. 8, 464-478.
2. Adhikary, S. and Ellers, M. (2005). Transcriptional regulation and transformation by Myc proteins. Nat. Rev. Mol. Cell. Biol. 6, 635-645.
3. Baena, E., Gandarillas, A., Vallespinos, M., Zanet, J., Bachs, O., Redondo, C., Fabregat, I., Martinez, A. C. and de Alboran, I. M. (2005). c-Myc regulates cell size and ploidy but is not essential for postnatal proliferation in liver. Proc. Natl. Acad. Sci. USA 102, 7286-7291.
4. Baudino, T. A., McKay, C., Pendeville-Samain, H., Nilsson, J. A., Maclean, K. H., White, E. L., Davis, A. C., Ihle, J. N. and Cleveland, J. L. (2002). c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. Genes Dev. 16, 2530-2543.
5. Beck, L., Jr and D'Amore, P. A. (1997). Vascular development: cellular and molecular regulation. FASEB J. 11, 365-373.
6. Benitah, S. A., Frye, M., Glogauer, M. and Watt, F. M. (2005). Stem cell depletion through epidermal deletion of Rac1. Science 309, 933-935.
7. Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z. et al. (2000). Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2, 737-744.
8. Bettess, M. D., Dubois, N., Murphy, M. J., Dubey, C., Roger, C., Robine, S. and Trumpp, A. (2005). c-Myc is required for the formation of intestinal crypts but dispensable for homeostasis of the adult intestinal epithelium. Mol. Cell Biol. 25, 7868-7878.
9. Braren, R., Hu, H., Kim, Y. H., Beggs, H. E., Reichardt, L. F. and Wang, R. (2006). Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation. J. Cell Biol. 172, 151-162.
10. Bull, J. J., Muller-Rover, S., Patel, S. V., Chronnell, C. M., McKay, I. A. and Philpott, M. P. (2001). Contrasting localization of c-Myc with other Myc superfamily transcription factors in the human hair follicle and during the hair growth cycle. J. Invest. Dermatol. 116, 617-622.
11. Carmeliet, P. (2005). Angiogenesis in life, disease and medicine. Nature 438, 932-936.
12. Carpenter, B., Lin, Y., Stoll, S., Raffai, R. L., McCuskey, R. and Wang, R. (2005). VEGF is crucial for the hepatic vascular development required for lipoprotein uptake. Development 132, 3293-3303.
13. Cumano, A. and Godin, I. (2007). Ontogeny of the hematopoietic system. Annu. Rev. Immunol. 25, 745-785.
14. Davis, A. C., Wims, M., Spotts, G. D., Hann, S. R. and Bradley, A. (1993). A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev. 7, 671-682.
15. de Boer, J., Williams, A., Skavdis, G., Harker, N., Coles, M., Tolaini, M., Norton, T., Williams, K., Roderick, K., Potocnik, A. J. et al. (2003). Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur. J. Immunol. 33, 314-325.
16. de, Bruijn, M. F., Ma, X., Robin, C., Ottersbach, K., Sanchez, M. J. and Dzierzak, E. (2002). Hematopoietic stem cells localize to the endothelial cell layer in the midgestation mouse aorta. Immunity 16, 673-683.
17. Dews, M., Homayouni, A., Yu, D., Murphy, D., Sevignani, C., Wentzel, E., Furth, E. E., Lee, W. M., Enders, G. H., Mendell, J. T. et al. (2006). Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat. Genet. 38, 1060-1065.
18. Downs, K. M., Martin, G. R. and Bishop, J. M. (1989). Contrasting patterns of myc and N-myc expression during gastrulation of the mouse embryo. Genes Dev. 3, 860-869.
19. Dubois, N. C., Adolphe, C., Ehninger, A., Wang, R. A., Robertson, E. J. and Trumpp, A. (2008). Placental rescue reveals a sole requirement for c-Myc in embryonic erythroblast survival and hernatopoietic stem cell function. Development 135, 2455-2465.
20. Eichmann, A., Pardanaud, L., Yuan, L. and Moyon, D. (2002). Vasculogenesis and the search for the hemangioblast. J. Hematother. Stem Cell Res. 11, 207-214.
21. Ema, M. and Rossant, J. (2003). Cell fate decisions in early blood vessel formation. Trends Cardiovasc. Med. 13, 254-259.
22. Erlebacher, A., Price, K. A. and Glimcher, L. H. (2004). Maintenance of mouse trophoblast stem cell proliferation by TGF-beta/ activin. Dev. Biol. 275, 158-169.
23. Evan, G. I., Christophorou, M., Lawlor, E. A., Ringshausen, I., Prescott, J., Dansen, T., Finch, A., Martins, C. and Murphy, D. (2005). Oncogene-dependent tumor suppression: using the dark side of the force for cancer therapy. Cold Spring Harb. Symp. Quant. Biol. 70, 263-273.
24. Folkman, J. (2006). Angiogenesis. Annu. Rev. Med. 57, 1-18.
25. Gekas, C., Dieterlen-Lievre, F., Orkin, S. H. and Mikkola, H. K. (2005). The placenta is a niche for hematopoietic stem cells. Dev. Cell 8, 365-375.
26. Grandori, C., Cowley, S. M., James, L. P. and Eisenman, R. N. (2000). The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16, 653-699.
27. Graven, K. K., Zimmerman, L. H., Dickson, E. W., Weinhouse, G. L. and Farber, H. W. (1993). Endothelial cell hypoxia associated proteins are cell and stress specific. J. Cell Physiol. 157, 544-554.
28. Guney, I. and Sedivy, J. M. (2006). Cellular senescence, epigenetic switches and c-Myc. Cell Cycle 5, 2319-2323.
29. Gustafsson, E., Brakebusch, C., Hietanen, K. and Fassler, R. (2001). Tie-1-directed expression of Cre recombinase in endothelial cells of embryoid bodies and transgenic mice. J. Cell Sci. 114, 671-676.
30. Hanahan, D. and Folkman, J. (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364.
31. Hayashi, S., Lewis, P., Pevny, L. and McMahon, A. P. (2002). Efficient gene modulation in mouse epiblast using a Sox2Cre transgenic mouse strain. Mech. Dev. 119 Suppl. 1, S97-S101.
32. Iljin, K., Petrova, T. V., Veikkola, T, Kumar, V., Poutanen, M. and Alitalo, K. (2002). A fluorescent Tie1 reporter allows monitoring of vascular development and endothelial cell isolation from transgenic mouse embryos. FASEB J. 16, 1764-1774.
33. Ivanova, N. B., Dimos, J. T., Schaniel, C., Hackney, J. A., Moore, K. A. and Lemischka, I. R. (2002). A stem cell molecular signature. Science 298, 601-604.
34. Jones, E. A., Baron, M. H., Fraser, S. E. and Dickinson, M. E. (2004). Measuring hemodynamic changes during mammalian development. Am. J. Physiol. Heart Circ. Physiol. 287, H1561-H1569.
35. Knies-Bamforth, U. E., Fox, S. B., Poulsom, R., Evan, G. I. and Harris, A. L. (2004). c-Myc interacts with hypoxia to induce angiogenesis in vivo by a vascular endothelial growth factor-dependent mechanism. Cancer Res. 64, 6563-6570,
36. Kopp, H. G., Ramos, C. A. and Rafii, S. (2006). Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and schemic tissue. Curr. Opin. Hematol. 13, 175-181.
37. Li, F., Xiang, Y., Potter, J., Dinavahi, R., Dang, C. V. and Lee, L. A. (2006). Conditional deletion of c-myc does not impair liver regeneration. Cancer Res. 66, 5608-5612.
38. Lucitti, J. L., Jones, E., A, Huang, C., Chen, J., Fraser, S. E. and Dickinson, M. E. (2007). Vascular remodeling of the mouse yolk sac requires hemodynamic force. Development 134, 3317-3326.
39. Malynn, B. A., de Alboran, I. M., O'Hagan, R. C., Bronson, R., Davidson, L., DePinho, R. A. and Alt, F. W. (2000). N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Genes Dev. 14, 1390-1399.
40. Mezquita, P., Parghi, S. S., Brandvold, K. A. and Ruddell, A. (2005). Myc regulates VEGF production in B cells by stimulating initiation of VEGF mRNA translation. Oncogene 24, 889-901.
41. Mikkola, H. K. and Orkin, S. H. (2006). The journey of developing hematopoietic stem cells. Development 133, 3733-3744.
42. Mikkola, H. K., Gekas, C., Orkin, S. H. and Dieterlen-Lievre, F. (2005). Placenta as a site for hematopoietic stem cell development. Exp. Hematol. 33, 1048-1054.
43. Mountain, D. J., Singh, M., Menon, B. and Singh, K. (2007). Interleukin-1beta increases expression and activity of matrix metalloproteinase-2 in cardiac microvascular endothelial cells: role of PKCalpha/beta1 and MAPKs. Am. J. Physiol. Cell Physiol. 292, C867-C875.
44. Muncan, V., Sansom, O. J., Tertoolen, L., Phesse, T. J., Begthel, H., Sancho, E., Cole, A. M., Gregorieff, A., de Alboran, I. M., Clevers, H. et al. (2006). Rapid loss of intestinal crypts upon conditional deletion of the Wnt/Tcf-4 target gene c-Myc. Mol. Cell Biol. 26, 8418-8426.
45. Murphy, M. J., Wilson, A. and Trumpp, A. (2005). More than just proliferation: 0Myc function in stem cells. Trends Cell Biol. 15, 128-137.
46. Ogilvy, S., Metcalf, D., Gibson, L., Bath, M. L., Harris, A. W. and Adams, J. M. (1999). Promoter elements of vav drive transgene expression in vivo throughout the hematopoietic compartment. Blood 94, 1855-1863.
47. Okamoto, R., Ueno, M., Yamada, Y., Takahashi, N., Sano, H., Suda, T. and Takakura, N. (2005). Hematopoietic cells regulate the angiogenic switch during tumorigenesis. Blood 105, 2757-2763.
48. Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G. and Downing, J. R. (1996). AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84, 321-330.
49. Oskarsson, T., Essers, M. A., Dubois, N., Offner, S., Dubey, C., Roger, C., Metzger, D., Chambon, P., Hummler, E., Beard, P. et al. (2006). Skin epidermis lacking the c-Myc gene is resistant to Ras-driven tumorigenesis but can reacquire sensitivity upon additional loss of the p21Cip1 gene. Genes Dev. 20, 2024-2029.
50. Pelengaris, S., Khan, M. and Evan, G. (2002). c-MYC: more than just a matter of life and death. Nat. Rev. Cancer 2, 764-776.
51. Ramirez-Bergeron, D. L., Runge, A., Adelman, D. M., Gohil, M. and Simon, M. C. (2006). HIF-dependent hematopoetic factors regulate the development of the embryonic vasculature. Dev. Cell 11, 81-92.
52. Randall, T. D. and Weissman, I. L. (1997). Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment. Blood 89, 3596-3606.
53. Robb, L., Lyons, I., Li, R., Hartley, L., Kontgen, F., Harvey, R. P., Metcalf, D. and Begley, C. G. (1995). Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc. Natl. Acad. Sci. USA 92, 7075-7079.
54. Shchors, K., Shchors, E., Rostker, F., Lawlor, E. R., Brown-Swigart, L. and Evan, G. I. (2006), The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta. Genes Dev. 20, 2527-2538.
55. Shojaei, F., Wu, X., Zhong, C., Yu, L., Liang, X. H., Yao, J., Blanchard, D., Bais, C., Peale, F. V., van Bruggen, N. et al. (2007). Bv8 regulates myeloid-cell-dependent tumour angiogenesis. Nature 450, 825-831.
56. Srinivas, S., Watanabe, T., Lin, C. S., William, C. M., Tanabe, Y., Jessell, T. M. and Costantini, F. (2001). Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1, 4.
57. Takakura, N., Watanabe, T., Suenobu, S., Yamada, Y., Noda, T., Ito, Y., Satake, M. and Suda, T. (2000). A role for hematopoietic stem cells in promoting angiogenesis. Cell 102, 199-209.
58. Taoudi, S. and Medvinsky, A. (2007). Functional identification of the hematopoietic stem cell niche in the ventral domain of the embryonic dorsal aorta. Proc. Natl. Acad. Sci. USA 104, 9399-9403.
59. Thurston, G., Noguera-Troise, I. and Yancopoulos, G. D. (2007). The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth. Nat. Rev. Cancer 7, 327-331.
60. Tordjman, R., Delaire, S., Plouët, J., Ting, S., Gaulard, P., Fichelson, S., Roméo, P. H. and Lemarchandel, V. (2001). Erythroblasts are a source of angiogenic factors. Blood 97, 1968-1974.
61. Trumpp, A., Refaeli, Y., Oskarsson, T., Gasser, S., Murphy, M., Martin, G. R. and Bishop, J. M. (2001). c-Myc regulates mammalian body size by controlling cell number but not cell size. Nature 414, 768-773.
62. Vincent, S. D. and Robertson, E. J. (2003). Highly efficient transgene-independent recombination directed by a maternally derived SOX2CRE transgene. Genesis 37, 54-56.
63. Watnick, R. S., Cheng, Y. N., Rangarajan, A., Ince, T. A. and Weinberg, R. A. (2003). Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis. Cancer Cell 3, 219-231.
64. Wilson, A., and Trumpp, A. (2006). Bone-marrow haematopoietic-stem-cell niches. Nat. Rev. Immunol. 6, 93-106.
65. Wilson, A., Murphy, M. J., Oskarsson, T., Kaloulis, K., Bettess, M. D., Oser, G. M., Pasche, A. C., Knabenhans, C., Macdonald, H. R. and Trumpp, A. (2004). c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev. 18, 2747-2763.